Results 121 to 130 of about 6,938 (195)

CD95/Fas ligand induced toxicity. [PDF]

Biochem Soc Trans, 2023
Haluck-Kangas A, Peter ME.
europepmc   +1 more source

Fas Ligand (CD95L) and Cancer Gene Therapy [PDF]

Nature Biotechnology, 1999
openaire   +1 more source

CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models. [PDF]

J Neurooncol, 2022
Quijano-Rubio C, Silginer M, Weller M.
europepmc   +1 more source

DISE, an ancient anti-cancer mechanism that senses mutational load in cancerous cells? [PDF]

Oncotarget, 2023
Patel M, Peter ME.
europepmc   +1 more source

A mathematical modeling technique to understand the role of decoy receptors in ligand-receptor interaction. [PDF]

Sci Rep, 2023
Dey S, Ghosh A, Banerjee M.
europepmc   +1 more source

Semisynthetic Ferritin Nanocages for Flexible, Site-Specific Targeting and Ligand-Free Activation of Membrane Receptors. [PDF]

Nano Lett
Neusch A, Siepe C, Zitzke L, Fux AC, Monzel C.   +4 more
europepmc   +1 more source

Model composition through model reduction: a combined model of CD95 and NF-κB signaling pathways [PDF]

, 2013

core   +1 more source

CD95/Fas stoichiometry in future precision medicine. [PDF]

Cell Death Differ
Sica M, Roussel M, Legembre P.
europepmc   +1 more source

Dendritic cells and the balance between transplant tolerance and immunity [PDF]

, 1996
Lu, L, Starzl, TE, Steptoe, RJ, Thomson, AW   +3 more
core  

Protocol for measuring the caspase-8 activity at the DED filaments in adherent cells. [PDF]

STAR Protoc
König C, Lavrik IN.
europepmc   +1 more source